CCEP today hosts a Capital Markets Event in Manila for analysts and investors. Chair Sol Daurella, Chief Executive Damian Gammell and members of the executive leadership team will present our growth ...

PRISMAFLEX INTERNATIONAL - Increase in Q4 total sales by +10.9% - 2024-2025 annual revenue: EUR 54.9 million, up +6.1% - ...

THE BLOCKCHAIN GROUP - The Blockchain Group announces a convertible bond issuance of - EUR 12.1M to accelerate its Bitcoin ...

Turnover (€M) 2024-2025 2023-2024 Change Change at constant exchange rates 4th quarter 83.3 80.1 +4.0% +3.8% O/w Closures ...

KLEA HOLDING (FR0013481835 – ALKLH), a group focused on the acquisition, development, and digitalization of companies across ...

AMOEBA - Amoéba and Koppert continue to prepare the commercial launch of AXPERA, the biocontrol product developed by Amoéba.

FERMENTALG - The FDA's approval of Fermentalg's natural blue dye paves the way for a new generation of bio-based products in ...

Resolution 24 is a standing item at each Annual General Meeting of the Company to enable CCEP to give effect to Resolutions 27 and 28. Therefore, a share repurchase cannot occur unless Resolution 24 ...

Atlas Special Opportunities, LLC has converted 4 convertible bonds in Oxurion resulting in a EUR 100,000 capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital ...

The purchases form part of the Company's share buyback programme announced on 14 February 2025 (the "Programme"). In connection with the Programme, the Company expects to repurchase up to EUR 1 ...

Highest price paid (per ordinary share) USD 91.3600 GBP 69.1000 GBP 69.1000 GBP 69.2000 Lowest price paid (per ordinary share) USD 89.9100 GBP 67.7000 GBP 67.8000 GBP 67.7000 Volume weighted average ...